150 related articles for article (PubMed ID: 30362552)
1. Identification of CD28 and PTEN as novel prognostic markers for cervical cancer.
Shen F; Zheng H; Zhou L; Li W; Liu J; Xu X
J Cell Physiol; 2019 May; 234(5):7004-7011. PubMed ID: 30362552
[TBL] [Abstract][Full Text] [Related]
2. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
3. A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer.
Chen H; Li H; Wang L; Li Y; Yang C
J Obstet Gynaecol; 2022 Feb; 42(2):327-332. PubMed ID: 34082663
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Nuclear Encoded Mitochondrial Gene Networks in Cervical Cancer.
Meneur C; Eswaran S; Adiga D; S S; G NK; Mallya S; Chakrabarty S; Kabekkodu SP
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1799-1811. PubMed ID: 34181336
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
Li C; Ke J; Liu J; Su J
J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
[TBL] [Abstract][Full Text] [Related]
6. Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
Shi C; Yang Y; Zhang L; Zhang T; Yu J; Qin S; Gao Y
Oncol Rep; 2019 Jun; 41(6):3167-3178. PubMed ID: 30942460
[TBL] [Abstract][Full Text] [Related]
7. Identification of gene-specific DNA methylation signature for Colorectal Cancer.
Li K; Zeng L; Wei H; Hu J; Jiao L; Zhang J; Xiong Y
Cancer Genet; 2018 Dec; 228-229():5-11. PubMed ID: 30553473
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
9. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract][Full Text] [Related]
10. Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.
Han HY; Mou JT; Jiang WP; Zhai XM; Deng K
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33616161
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the exocytosis pathway genes in cervical cancer.
Eswaran S; Adiga D; Khan G N; S S; Kabekkodu SP
Am J Med Sci; 2022 Jun; 363(6):526-537. PubMed ID: 34995576
[TBL] [Abstract][Full Text] [Related]
12. A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.
Ju M; Qi A; Bi J; Zhao L; Jiang L; Zhang Q; Wei Q; Guan Q; Li X; Wang L; Wei M; Zhao L
J Cell Mol Med; 2020 Jun; 24(11):6283-6297. PubMed ID: 32306508
[TBL] [Abstract][Full Text] [Related]
13. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
14. Identification of pyroptosis-related signature for cervical cancer predicting prognosis.
Zhou C; Li C; Zheng Y; Liu X
Aging (Albany NY); 2021 Nov; 13(22):24795-24814. PubMed ID: 34837692
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of aberrant gene expression and methylation profiles reveals susceptibility genes and underlying mechanism of cervical cancer.
Lin H; Ma Y; Wei Y; Shang H
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():147-152. PubMed ID: 27863272
[TBL] [Abstract][Full Text] [Related]
16. Cellular retinol binding protein 1 could be a tumor suppressor gene in cervical cancer.
Mendoza-Rodriguez M; Arreola H; Valdivia A; Peralta R; Serna H; Villegas V; Romero P; Alvarado-Hernández B; Paniagua L; Marrero-Rodríguez D; Meraz MA; Salcedo M
Int J Clin Exp Pathol; 2013; 6(9):1817-25. PubMed ID: 24040446
[TBL] [Abstract][Full Text] [Related]
17. A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.
Zheng S; Luo X; Dong C; Zheng D; Xie J; Zhuge L; Sun Y; Chen H
Int J Cancer; 2018 Nov; 143(10):2592-2601. PubMed ID: 30152019
[TBL] [Abstract][Full Text] [Related]
18. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
Qin R; Cao L; Wang J; Liu J
Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
[TBL] [Abstract][Full Text] [Related]
19. TOP2A and CENPF are synergistic master regulators activated in cervical cancer.
Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
